
High-end Medical Device R&D and Manufacturer
MicroPort Medical(00853) announced that on March 31, 2021, the Board of Directors granted a total of approximately 1.4494 million share options to 61 eligible participants of the Company, entitling them to subscribe for up to 1.4494 million shares of the Company. The exercise price per share is HK$43.75, with a validity period of 10 years.
Among them, Mr. Chang Zhaohua, Chairman and Chief Executive Officer of the Company, is one of the grantees, having been granted a total of 36,940 share options.